DexCom (DXCM) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

DexCom (DXCM) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 19, 2024 (15:10)

Sector: Healthcare

The share price of DexCom, Inc. (DXCM) now

Latest session on the 18th of July for
DexCom, Inc. is negative
Trading Volume: 2848504
Open: 114.49 /  High: 116.345 /  Low: 110.65
What analysts predict: $151.59
52-week High/Low: $142 / $74.75

50/200 Day Moving Average: $118.66 / $119.13

This figure corresponds to the Average Price over the previous 50/200 days. For DexCom stocks, the 50-day moving average is the resistance level today.

For DexCom stocks, the 200-day moving average is the resistance level today.

Are you interested in DexCom, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the DexCom stock price in 2024, 2025, 2026, 2027, 2028. How much will one DexCom share be worth in 2024 - 2028?

When should I take profit in DexCom stock? When should I record a loss on DexCom stock? What are analysts' forecasts for DexCom stock? What is the future of DexCom stock? We forecast DexCom stock performance using neural networks based on historical data on DexCom stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

DexCom stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for DexCom shares. This happens once a day.


Historical and forecast chart of DexCom stock

The chart below shows the historical price of DexCom stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the DexCom stock price can be found in the table below.

Long-term forecasts by years.

Dexcom, Inc. is a medical equipment company. The company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare professionals. Its products include Dexcom G6 and Dexcom stake. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which can include automated insulin dosing systems, insulin pumps, blood glucose meters, or other electronic devices used to treat diabetes. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on a patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transfer glucose information to the cloud and then to apps on mobile devices to up to five designated recipients who can remotely monitor patient glucose information and receive alerts.

DexCom daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 21 109.84 108.45 110.91 2.27
Jul 22 108.83 107.43 109.91 2.31
Jul 23 109.09 107.60 109.85 2.09
Jul 24 108.96 108.28 109.92 1.51
Jul 25 110.57 109.00 111.70 2.48
Jul 26 112.36 111.03 114.09 2.75
Jul 27 113.30 112.10 114.35 2.00
Jul 28 114.44 113.13 115.83 2.39
Jul 29 114.80 113.84 115.74 1.67
Jul 30 114.23 113.61 115.26 1.45
Jul 31 115.19 113.65 116.27 2.31
Aug 01 116.43 115.55 117.34 1.55
Aug 02 116.62 115.08 118.16 2.68
Aug 03 118.83 117.88 119.52 1.39
Aug 04 119.29 118.43 119.93 1.27
Aug 05 120.43 118.77 122.29 2.96
Aug 06 120.36 119.42 121.80 2.00
Aug 07 122.07 120.92 122.85 1.60
Aug 08 120.80 119.37 122.42 2.55
Aug 09 118.55 117.41 119.67 1.92
Aug 10 117.86 117.06 118.41 1.15
Aug 11 118.05 116.57 118.64 1.78
Aug 12 118.93 118.12 120.45 1.97
Aug 13 118.47 117.88 120.25 2.01
Aug 14 120.32 118.81 121.07 1.90
Aug 15 122.32 120.41 123.23 2.34
Aug 16 120.88 119.81 122.16 1.96
Aug 17 119.04 118.52 119.80 1.09
Aug 18 117.04 116.06 118.63 2.22
Aug 19 117.65 116.52 118.85 2.00

DexCom Daily Price Targets


DexCom Stock Forecast 07-21-2024.

Forecast target price for 07-21-2024: $109.84.
Negative dynamics for DexCom shares will prevail with possible volatility of 2.219%.
Pessimistic target level: 108.45
Optimistic target level: 110.91

DexCom Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $108.83.
Negative dynamics for DexCom shares will prevail with possible volatility of 2.257%.
Pessimistic target level: 107.43
Optimistic target level: 109.91

DexCom Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $109.09.
Positive dynamics for DexCom shares will prevail with possible volatility of 2.046%.
Pessimistic target level: 107.60
Optimistic target level: 109.85

DexCom Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $108.96.
Negative dynamics for DexCom shares will prevail with possible volatility of 1.488%.
Pessimistic target level: 108.28
Optimistic target level: 109.92

DexCom Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $110.57.
Positive dynamics for DexCom shares will prevail with possible volatility of 2.415%.
Pessimistic target level: 109.00
Optimistic target level: 111.70

DexCom Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $112.36.
Positive dynamics for DexCom shares will prevail with possible volatility of 2.679%.
Pessimistic target level: 111.03
Optimistic target level: 114.09

DXCM (DXCM) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 113.60 110.51 119.51 7.53
Sep. 119.69 113.75 126.59 10.14
Oct. 123.43 118.39 128.76 8.05
Nov. 118.19 112.61 121.31 7.17
Dec. 112.33 105.59 117.09 9.82

DexCom forecast for this year


DexCom Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $113.601. Pessimistic: $110.51. Optimistic: $119.51


DexCom Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $119.69. Pessimistic: $113.75. Optimistic: $126.59


DexCom Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $123.425. Pessimistic: $118.39. Optimistic: $128.76


DexCom Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $118.192. Pessimistic: $112.61. Optimistic: $121.31


DexCom Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $112.329. Pessimistic: $105.59. Optimistic: $117.09



DexCom (DXCM) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 120.24 115.43 123.51 6.54
Feb 122.83 115.46 128.04 9.82
Mar 118.51 112.73 120.50 6.45
Apr 114.72 111.60 118.02 5.44
May 109.95 105.37 114.61 8.06
Jun 104.85 102.16 108.87 6.16
Jul 104.68 100.91 106.69 5.42
Aug 104.51 102.50 108.36 5.40
Sep 101.50 97.52 106.86 8.74
Oct 106.29 100.08 110.63 9.53
Nov 109.52 106.28 112.41 5.46
Dec 116.97 114.44 123.33 7.21

DexCom (DXCM) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 113.88 111.79 119.99 6.83
Feb 114.88 109.00 117.55 7.27
Mar 116.35 114.03 120.08 5.04
Apr 113.00 110.02 116.53 5.59
May 114.18 109.15 116.01 5.91
Jun 115.55 110.28 119.89 8.02
Jul 115.55 110.74 117.49 5.74
Aug 120.91 113.95 126.23 9.73
Sep 130.49 126.62 136.75 7.40
Oct 131.01 126.29 139.08 9.19
Nov 129.33 124.68 136.88 8.92
Dec 125.81 123.70 131.15 5.68

DexCom (DXCM) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 127.02 123.26 133.83 7.90
Feb 119.60 112.24 125.06 10.25
Mar 119.22 112.16 126.09 11.04
Apr 121.60 115.77 129.29 10.46
May 121.12 114.82 127.61 10.02
Jun 128.00 124.00 133.53 7.13
Jul 131.89 129.78 134.42 3.45
Aug 126.93 123.58 131.91 6.31
Sep 133.33 128.21 137.91 7.04
Oct 137.70 134.84 144.75 6.85
Nov 131.20 125.53 136.24 7.86
Dec 127.00 123.34 129.75 4.93

DexCom (DXCM) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 129.85 126.32 135.98 7.10
Feb 128.60 123.77 134.36 7.89
Mar 126.95 121.88 130.41 6.54
Apr 131.73 126.35 140.05 9.78
May 136.47 129.70 142.69 9.10
Jun 144.00 137.90 147.92 6.78
Jul 150.22 143.85 154.79 7.07
Aug 160.44 154.02 164.80 6.54
Sep 170.32 162.28 179.72 9.70
Oct 163.78 156.97 172.82 9.17
Nov 166.27 156.43 171.59 8.84
Dec 164.81 158.08 170.87 7.48

DexCom information and performance

DexCom Address

6340 SEQUENCE DRIVE, SAN DIEGO, CA, US

Market Capitalization: 45 970 756 000 $

Market capitalization of the DexCom, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DXCM shares in the company outstanding by the market price of one share.

EBITDA: 848 500 000 $

EBITDA of DexCom is earnings before interest, income tax and depreciation of assets.

PE Ratio: 74.42

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.532

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.54

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 1.987
Quarterly Revenue Growth YOY: 0.242
Trailing PE: 74.42

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 77.52

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 14.46

Enterprise Value (EV) /Revenue

EV To EBITDA: 57.12

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 397684000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.